NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry ...
Third party commercial assessment shows larger than expected potential total addressable market for IGALMI® in the at-home settingStrong ...
Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.
A new study published in Translational Psychiatry suggests that chronic cannabis use may not be associated with cognitive ...
The medicine is manufactured in Japan and Italy. The drug Latuda, which is used to treat schizophrenia and bipolar disorder ...
Emerging research links the gut microbiome to mood stability. Here’s what you need to know about the benefits, limitations, and safety of probiotics. Key Takeaways ______________ Note: The U.S. Food ...